These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4761552)

  • 1. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
    Azzaro AJ; Rutledge CO
    Biochem Pharmacol; 1973 Nov; 22(22):2801-13. PubMed ID: 4761552
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychoactive drugs and neurotransmitters: differentiating dopamine and norepinephrine neuronal functions with drugs.
    Snyder SH; Taylor KM; Horn AS; Coyle JT
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():359-75. PubMed ID: 4341952
    [No Abstract]   [Full Text] [Related]  

  • 4. Developmental and regional variations in neurotransmitter-sensitive adenylate cyclase systems in cell-free preparations from rat brain.
    Von Hungen K; Roberts S; Hill DF
    J Neurochem; 1974 May; 22(5):811-9. PubMed ID: 4407101
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine.
    Glowinski J; Axelrod J; Iversen LL
    J Pharmacol Exp Ther; 1966 Jul; 153(1):30-41. PubMed ID: 4380692
    [No Abstract]   [Full Text] [Related]  

  • 6. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices.
    Westfall TC
    Neuropharmacology; 1974 Aug; 13(8):693-700. PubMed ID: 4216859
    [No Abstract]   [Full Text] [Related]  

  • 8. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
    Raiteri M; Bertollini A; Angelini F; Levi G
    Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
    Wenger GR; Rutledge CO
    J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):328-36. PubMed ID: 581027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of dopamine, norepinephrine and 5-hydroxytryptamine in different regions of the rat brain in thallium toxicosis.
    Hasan M; Ali SF; Tariq M
    Acta Pharmacol Toxicol (Copenh); 1978 Sep; 43(3):169-73. PubMed ID: 707129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats.
    Lokiec F; Jacquot C; Rapin JR; Cohen Y
    Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of delta9-tetrahydrocannabinol on brain amine concentration and turnover in whole rat brain and in various regions of the brain.
    Bracs P; Jackson DM; Chesher GB
    J Pharm Pharmacol; 1975 Sep; 27(9):713-5. PubMed ID: 241821
    [No Abstract]   [Full Text] [Related]  

  • 16. Central supersensitivity to norepinephrine and amphetamine following brain chemical sympathectomy by 6-hydroxydopamine.
    Blum K; Wallace JE; Schwertner HA; Meyer E; Morgan WW
    Life Sci; 1977 May; 20(10):1705-13. PubMed ID: 875616
    [No Abstract]   [Full Text] [Related]  

  • 17. Rotational behaviour produced in rats by unilateral electrolytic lesions of the ascending noradrenergic bundles.
    Donaldson IM; Dolphin AC; Jenner P; Pycock C; Marsden CD
    Brain Res; 1977 Dec; 138(3):487-509. PubMed ID: 597720
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hypo- and hyperthyroidism on regional monoamine metabolism in the adult rat brain.
    Ito JM; Valcana T; Timiras PS
    Neuroendocrinology; 1977; 24(1):55-64. PubMed ID: 600365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of amphetamine-induced release of 5-HT from rat hippocampal slices.
    Balfour DJ; Iyaniwura TT
    Eur J Pharmacol; 1985 Mar; 109(3):395-9. PubMed ID: 3987808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain.
    Marsden CA; Guldberg HC
    Neuropharmacology; 1973 Mar; 12(3):195-211. PubMed ID: 4266877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.